Stocks
BioMarin Pharmaceutical (BMRN) Debt/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| Debt/EBITDA | 1.60 | -0.75 | 0.07 | -0.75 | -1.60 | -1.62 | ||
| Changes by years, y/y, % | +520% | -147% | -110% | -1 149% | +113% | |||
BioMarin Pharmaceutical. Debt/EBITDA
BioMarin Pharmaceutical. Debt/EBITDA, changes, %
BioMarin Pharmaceutical (BMRN) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | -0.86 | -0.89 | -1.13 | -1.60 | -1.62 | -1.62 | ||
| Changes by years, y/y, % | -720% | +200% | +75% | +95% | +88% | |||
| Changes by quarters, q/q, % | +5% | +3% | +28% | +42% | +1% | |||
